Conspicuous sales rise for Celebrex

Published: 2011-02-23 06:58:00
Updated: 2011-02-23 06:58:00
Pfizer's Celebrex gained a majority of sales for new-generation painkillers last year amid growing safety concerns over popular Gevorin and other acetaminophen drugs, according to Ubist market data.

Last year, sales of Celebrex topped 37.4 billion sales, showing more than 90 billion in each qu...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.